Girls who received the HPV vaccine in early adolescence now face almost no risk of dying from cervical cancer before 30, according to a study by Queen Mary University of London. The research, published in The Lancet, shows vaccinated women aged 30-34 have a 63% lower risk of death from the disease. Between 2020 and 2024, no women aged 20 to 24 in England died from cervical cancer.